Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy B London

Showing results (31-40 of 230) with videos related to

Pageof 23
Sort By:
Pediatric Blood & Cancer|August 16, 2008
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology GroupPeter E Zage, Morris Kletzel, Kevin Murray, et al.
Photomedicine and Laser Surgery|March 17, 2016
A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell TransplantationNathaniel S Treister, Wendy B London, Dongjing Guo, et al.
Pediatric Blood & Cancer|December 14, 2011
Tumor histology during induction therapy in patients with high-risk neuroblastomaRani E George, Antonio R Perez-Atayde, Xiaopan Yao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II studyHoward M Katzenstein, Wendy B London, Edwin C Douglass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group studyTara O Henderson, Smita Bhatia, Navin Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomasHiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
Pediatric Blood & Cancer|January 8, 2016
Newborn Screening for Sickle Cell Disease in Liberia: A Pilot StudyVenée N Tubman, Roseda Marshall, Wilhemina Jallah, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Cancer|September 9, 2017
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trialsWendy B London, Rochelle Bagatell, Brenda J Weigel, et al.
Pageof 23

Showing results (31-40 of 230) with videos related to

Sort By:
Pageof 23
Pediatric Blood & Cancer|August 16, 2008
Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology GroupPeter E Zage, Morris Kletzel, Kevin Murray, et al.
Photomedicine and Laser Surgery|March 17, 2016
A Feasibility Study Evaluating Extraoral Photobiomodulation Therapy for Prevention of Mucositis in Pediatric Hematopoietic Cell TransplantationNathaniel S Treister, Wendy B London, Dongjing Guo, et al.
Pediatric Blood & Cancer|December 14, 2011
Tumor histology during induction therapy in patients with high-risk neuroblastomaRani E George, Antonio R Perez-Atayde, Xiaopan Yao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II studyHoward M Katzenstein, Wendy B London, Edwin C Douglass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group studyTara O Henderson, Smita Bhatia, Navin Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomasHiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
Pediatric Blood & Cancer|January 8, 2016
Newborn Screening for Sickle Cell Disease in Liberia: A Pilot StudyVenée N Tubman, Roseda Marshall, Wilhemina Jallah, et al.
JCO Clinical Cancer Informatics|October 15, 2020
Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and FutureWayne H Liang, Sara M Federico, Wendy B London, et al.
Pediatric Blood & Cancer|February 18, 2011
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology GroupArlene Naranjo, Marguerite T Parisi, Barry L Shulkin, et al.
Cancer|September 9, 2017
Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trialsWendy B London, Rochelle Bagatell, Brenda J Weigel, et al.
Pageof 23